Announcements Trials

Browse Landscape

Phase

Status

Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Melanoma 9 Carcinoma, Non-Small-Cell Lung 3 Thyroid Neoplasms 2 Skin Neoplasms 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Multiple Myeloma 2 Lymphoma 2 Lung Neoplasms 2 Hematologic Neoplasms 2 Breast Neoplasms 2 Brain Neoplasms 2 Uveal Melanoma 1 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Thyroid Diseases 1 Stomach Neoplasms 1 Solid Tumor 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Neoplasm Metastasis 1 Leukemia, Hairy Cell 1 Klatskin Tumor 1 Glioma 1 Gastrointestinal Stromal Tumors 1 Gallbladder Neoplasms 1 Eye Neoplasms 1 Esophageal Neoplasms 1

Interventions

pembrolizumab 3 zimberelimab 1 tilsotolimod 1 sintilimab 1 sacituzumab govitecan 1 niraparib 1 encorafenib 1 cobimetinib 1 cedazuridine 1 binimetinib 1 atezolizumab 1 Radiosurgery 1 Proton Therapy 1 Nivolumab 1 Ipilimumab 1 Everolimus 1 Decitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Solid Tumor × binimetinib × Clear all

NCT03839342 2026-06-08

BEAVER

University Health Network, Toronto

Phase 2 Active not recruiting

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡